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HYDROGEN PEROXIDE RELEASE BY OKIa1 (ANTI
DR--MONOCLONAL ANTIBODY) RESISTANT
ALVEOLAR MACROPHAGES IN TUBERCULOSIS
P. Selvaraj,  Rajiswamy, V.K. Vijayan, R. Prabhakar and P.R Narayanan
Phorbol myristate acetate (PMA) triggered hydrogen peroxide (H2O2)
release from alveolar macrophages and corresponding blood monocytes
were studied as a whole, in active tuberculosis, inactive tuberculosis
(treated), non-tuberculous lung disease patients and normal individuals.
Irrespective of the study subjects, the alveolar macrophages produced less
H2O2 than the corresponding blood monocytes. The alveolar macrophages
that were resistant to OKIa1 (Anti-DR monoclonal antibody and
complement treatment) produced an increased level of H2O2 than the
control ascites and complement treated alveolar macrophages. Moreover,
such increase in H2O2  release was not seen with peripheral blood
monocytes; more than 90% monocytes were OKIa1 resistant population.
These OKIa1 resistant alveolar macrophages are probably important in their
metabolic, microbicidal and the immunological functions.
Key Words : H 2 O 2  re lease,  human alveolar  macrophages,  blood
monocytes, OKIa1 resistant alveolar macrophages.
Alveolar macrophages are the mononuclear phagocyte population lining the alveoli of
the lung. These cells are mainly involved in killing and eliminating the pathogens.1 One of
the killing mechanisms is the respiratory burst. The capacity of these cells to produce
reactive oxygen intermediates upon stimulation (respiratory burst) is probably related to
the cellular capacity for microbicidal function; which represents one of the host defense
function against intracellular pathogens2-6.. The reactive oxygen intermediates such as
superoxide anions and hydrogen peroxide are well known for their highly toxic oxidant
activity for pathogens. It has been shown that macrophages and monocytes express
membrane receptors for phorbol myristate acetate (PMA)7,8. When these cells are
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stimulated with PMA, the YMA triggers the cells to produce superoxide anions and H2O2
through NADPH oxidase system.
It has been shown that alveolar macrophages are less efficient in their immune functions
such as antigen presentation to T-lymphocytes and interleukin-1 production9-11. It has been
mentioned that the alveolar cells are immunologically inert12.
It is well established that the immune region associated Ia antigens are responsible for
the immunological functions such as antigen presentation13 and mixed leucocyte reaction14.
Based on the phagocytic function, macrophage heterogeneity has been shown among the
Ia+ alveolar macrophages in disease status15 On the other hand, in a study carried out in.
the blood monocytes of tuberculosis patients, an increased level of Ia negative monocytes
have been shown. The same study also suggested that HLA-DR negative and -DR positive
phenotypes represent different stages of maturation16.
In our earlier report we have shown that the PMA induced H2O2 production by the
alveolar macrophages was similar among the active tuberculosis, inactive tuberculosis and
non-tuberculous lung disease patients. Further, the alveolar macrophages and the blood
monocytes of the active pulmonary tuberculosis patients and those of normal controls were
equally competent in producing H2O2, in vitro, upon stimulation with PMA
17.
In the present study, the PMA triggered H2O2 producing potential of alveolar
macrophages and the corresponding blood monocytes were compared. Further, the H2O2
producing potential of an alveolar macrophage population, which was resistant to OKIa1
(anti-DR monoclonal antibody) monoclonal antibody was studied. Even though the study
was carried out as a whole, the finding may be useful to understand the role of OKIa1
resistant alveolar macrophages in their microbicidal and immunological functions to the
intracellular pathogens such as M. tuberculosis.
Material and Methods
Study Subjects. The patients were suspected cases of pulmonary tuberculosis attending
Tuberculosis Research Centre with respiratory symptoms and radiographic evidence of
lung diseases of varying duration. All the patients had at least six sputum smears negative
for M. tuberculosis by microscopy. All patients sputa were cultured for  M. tuberculosis and
depending upon the culture results, these patients were classified into 3 groups.
Group 1. Active pulmonary tuberculosis. These patients had not received any previous
anti-tuberculosis chemotherapy and had grown M. tuberculosis in one or
more sputum specimens in culture (6 patients).
Group 2. Inactive pulmonary tuberculosis. These patients had had previous anti-
tuberculosis chemotherapy and presently their sputum showed culture
negativity for M. tuberculosis (5 patients).
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Group 3. Non-tuberculous lung disease. This group involved patients with lung
abscesses, bacterial pneumonia and pulmonary manifestations of
polycythemia vera (2 patients).
Group 4. Normal subjects who had normal chest x-ray and pulmonary functions and
were non-smokers (2 individuals).
Fibreoptic Bronchoscopy and Alveolar Lavage. Fibreoptic bronchoscopy procedure18 was
performed in the affected lobe and two other lobes, usually middle lobe and lingula. Each
lobe was lavaged with 100 ml isotonic sterile saline and the lavage samples were pooled and
the mucus was eliminated by filtration.
Alveolar Macrophages and Peripheral Blood Mononuclear Cells. The alveolar macrophages
of the lavage fluids were used for the hydrogen peroxide assay. The percentage dead cells
were from 10-15% as judged by trypan blue dye exclusion method. The per cent
neutrophils and eosinophils were, <3% and <2%, respectively. The alveolar cells were
washed in RPMI-1640 culture medium and resuspended in the same medium.
Peripheral blood mononuclear cells were separated using Ficoll-Hypaque as described
elsewhere19. The cells were washed thrice in RPMI medium and adjusted to 5 x 106 cells/ml
medium.
Non-Specific Esterase Staining. Smears of peripheral blood mononuclear cells were stained
for non-specific esterase for determining the percentage of monocyte population according
to the method of Horwitz20. A total number of 300 cells were counted and the per cent
monocytes (esterase positive cells) among them were determined.
Cytotoxicity Assay. HLA-DR negative alveolar macrophages were selected using antibody
and complement mediated conventional cytotoxicity assay by the method described by
Whisler, et al 21. Briefly, alveolar cells were incubated for 1 hr, at 4°C with 1 : 100 final
dilution of OKIa1 antibody in RPMI medium with 5% Foetal calf serum (Ortho Diagnostic
Systems Inc., U.S.A.) (an anti-HLA-DR antigen frame work complex expressed on B-cells,
activated T-cells and monocytes). Then the cell suspension was rinsed in RPMI containing
5% foetal calf serum and was further incubated for 1 hr at 37°C with 1: 4 final dilution of
rabbit complement. The cells were washed twice in RPMI medium. Cells treated with
control ascites and complement served as control. The percentage of cells susceptible to
OKIa1 monoclonal antibody and complement treatment was assessed by trypan blue dye
exclusion method and expressed as per cent cytotoxicity. Blood monocytes were also
treated in the same way. The alveolar macrophages and the blood monocytes which were
resistant to OKIa1 and complement treatment (HLA-DR negative cells) and the
corresponding control macrophages were studied for their hydrogen peroxide producing
potential. More than 95% of the OKIa1 resistant alveolar cells were macrophages, as
judged by Diff-quick staining and were all non-specific esterase positive.
H2O2 Assay. Hundred microliter containing 0.1 x 10
6 alveolar macrophages, or OKIa1
resistant alveolar macrophages/monocytes or, the control alveolar macrophages/
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monocytes were plated in 96 well plate. For peripheral blood, 0.5 x 106 blood mononuclear
cells were seeded in 96 well flat bottom plates (Falcon) and non-adherent cells were
removed by aspiration after one hour at 37°C. The adherent mononuclear cells (non-
specific esterase positive cells) and the alveolar macrophages were used for H2O2 assay.
The H2O2 assay method described by Pick and Mizel
22 was followed. Briefly, the plate
with the cells were washed with phenol red free Hank’s balanced salt solution (HBSS). 100
µl of HBSS containing 19 units/ml horse radish peroxidase (Type-III, Sigma), 1 µg/ml
phorbol myristate acetate (PMA) (Sigma) and 0.02% phenol red (Sigma) were added to
each well. After incubating the plate at 37°C for 1 hr the enzyme reaction was arrested with
10 µl of 1M NaOH. Absorbance at 605 mu was determined spectrophotometrically for the
assay mixture pooled from live wells. For each experiment a standard was set up in the
range of 0-10 n mol/ml of H2O2.
Results
In the present study, the alveolar macrophages of active tuberculosis, inactive
tuberculosis, non-tuberculous lung disease patients and normal subjects produced less
phorbol myristate acetate induced hydrogen peroxide when compared to the corresponding
blood monocytes (Table 1).
The alveolar macrophages that were susceptible to OKIa1 monoclonal antibody and
complement varied from 15-86%. The per cent susceptibility is expressed as per cent
cytotoxicity. The alveolar macrophage population which was resistant to OKIa1
Table 1. PMA induced hydrogen peroxide production by the alveolar macrophages and blood
monocytes in various groups of patients and normal individuals
Active TB 1)
2)*
3)*
4)
5)*
6)
Alveolar macrophages@ Blood monocytes@
2.0 8.2
6.2 10.1
12.3 5.1
3.9 7.9
3.8 4.7
2.0 4.9
Inactive TB 7) 4.0 12.0
(Treated) 8) 2.9 4.5
Non-TB lung 9) 10.8 27.1
disease 10) 2.6 10.3
Normal 11) 1.3 18.2
N.B. : @PMA induced hydrogen peroxide production in nmols per 0.1x106 alveolar macrophages or
blood monocytes.
Smokers
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monoclonal antibody and complement treatment produced more hydrogen peroxide than
the control ascites and complement treated population and the cells which were not
subjected to any treatment (Table 2). On the other hand, peripheral blood monocytes
which were resistant to OKIa1 monoclonal antibody produced an equal or slightly
increased/decreased level of hydrogen peroxide upon stimulation with PMA (Table 3).
More than 90% of the blood monocytes were resistant to OKIa1 monoclonal antibody and
complement treatment.
Discussion
In the present study, the alveolar macrophages produced less H2O2 than the blood
monocytes (Table 1). This lesser production of H2O2 could be due to the maturation of
monocyte/macrophage lineage which ultimately become less efficient. Majority of the
alveolar macrophages are felt to be derived from circulating blood monocytes23,24. A large
body of evidences showing that alveolar macrophages are less efficient in terms of antigen
presentation9, interleukin-1 production10,11, than the blood monocytes. At the same time,
when the monocytes mature in vitro, they lose the ability to elaborate IL-111. Whereas,
surface expression of HLA-DR class II MHC determinant was increased25 or, decreased26.
It has been shown that 6 days old monocyte derived macrophages and pulmonary
macrophages failed to function as accessory cells, which suggests that monocytes, as they
mature, become less efficient in their functions12.
Nakashima, et al 8 have shown that the PMA and the Con-A triggered, receptor
mediated, superoxide release was higher in the blood monocytes than the alveolar
macrophages. Further, it has been shown that blood monocytes, as they are in culture for
more than 3 days, the H2O2 production from day 4 onwards started decreasing which
suggests the maturation of monocytes to macrophages27.
The alveolar macrophages which were resistant of OKIa1 monoclonal antibody and
complement treatment produced an increased H2O2 than control ascites and complement
treated population. This resistant population of macrophages may be either a subset of
macrophages which are not susceptible to OKIa1 antibody and complement treatment or
may be immature in nature not expressing the -DR antigens recognizable by OKIa1
antibody. Albrechtsen28 studied human monocytes by using a cytotoxicity assay and an anti
HLA-DR hetero-antiserum and concluded that there was a sub-population of such cells
not lysed under the conditions of the assay, representing either Ia-negative monocytes or
cells with a quantity of surface Ia beneath the sensitivity. In a study carried out in blood
monocytes of tuberculosis patients and normal healthy individuals, it has been suggested
that HLA-DR negative and DR-positive phenotypes represent different stages of
maturation. These DR-negative monocytes were also found to reduce the lymphocyte
response to purified protein derivative (PPD) of M. tuberculosis, both in tuberculosis
patients and healthy subject16.
Moore and co-workers25 found that the density of HLA-DR surface expression was high
on alveolar macrophages than the monocytes. It has been substantiated that monocytes
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Table 2. PMA induced hydrogen peroxide producing potential of OKIa1 resistant alveolar macrophages
H2O2 in nmols/0.1 x 10
6 alveolar MØs
% Cytotoxicity@ Alveolar Control ascites OKIa1 antibody
cells$ + complement$ + complement$
Active TB *1) 86.1 2.4 2.7 7.0
*2) 44.3 3.8 3.9 5.3
Inactive TB *3) 42.1 2.0 3.5 9.0
(Treated) 4) 52.5 3.5 5.0 15.0
*5) 37.5 4.0 8.0 13.6
6) 45.4 4.4 6.7 7.9
7) 15.0 3.9 6.3 10.6
Non-TB lung *8) 58.0 6.8 8.7
diseases *9) 62.9 2.1 4.3 17.0
Normals 10) 60.0 1.3 1.3 2.2
11) 47.0 2.8 43 8.7
N.B. : @ Per cent alveolar macrophages susceptible to OKIa1 monoclonal antibody and rabbit
complement treatment.
$ Hydrogen peroxide production in nmols per 0.1 x 106 alveolar macrophages, either the
whole cells or mouse ascites and complement treated or, OKIa1 and complement treated
cells.
l Smokers.
Table 3. PMA induced H2O2 release by OKIa1 resistant peripheral blood monocytes
H2O2 in nmols/0.1x 10
6 blood monocytes
Control ascites
+ complement
@OKIa1 antibody
+ complement
Normal 18.5 19.8
Active TB 8.2 7.0
Non-TB 10.3 7.8
Non-TB* 7.0 7.5
N.B. : @ Per cent peripheral blood monocytes susceptible to OKIa1 monoclonal antibody and
complement were 6-10%.
l Smoker, Other are non-smokers.
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cultured more than 8 days express Ia-antigens and such cells are equivalent to that of
pulmonary macrophages in terms of their biochemical and functional aspects such as
antigen presentation to T-cells12.
In the present study, more than 90% of the peripheral blood monocytes were resistant
to OKIa1 monoclonal antibody. The increased production of H2O2 by the blood monocytes
than the alveolar macrophages could probably be due to their high level (>90%) of OKIa1
resistant population of monocytes in the blood.
The alveolar macrophages which were resistant to OKIa1 may be a newly recruited
monocyte-macrophage lineage not expressing a detectable level of Ia antigens on their
surface. It will be useful to study the role of these cells in their microbicidal and
immunological functions against intracellular pathogens.
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